E-LIB Suche - Ergebnisse für: Veelken, Philipp M.

1

Coupling Particle Ordering and Spherulitic Growth for Long-..:

Bobrov, Gleb ; Kedzior, Stephanie A. ; Pervez, Syed Atif...
ACS Applied Materials & Interfaces. 15 (2023) 1 - p. 1996-2008 , 2023

Link: https://doi.org/10.1021/..

2

Investigating the Interface between Ceramic Particles and P..:

Veelken, Philipp M. ; Wirtz, Maike ; Schierholz, Roland...
Nanomaterials. 12 (2022) 4 - p. 654 , 2022

Link: https://doi.org/10.3390/..

3

Polyethylene oxide‐Li6.5La3Zr1.5Ta0.5O12 hybrid electrolyte..:

Wirtz, Maike ; Linhorst, Max ; Veelken, Philipp...
Electrochemical Science Advances. 1 (2020) 2 - p. , 2020

Link: https://doi.org/10.1002/..

4

Additional cytogenetic features determine outcome in patien..:

Loke, Justin ; Labopin, Myriam ; Craddock, Charles...
Cancer. 128 (2022) 15 - p. 2922-2931 , 2022

Link: https://doi.org/10.1002/..

5

Antigen-independent, autonomous B cell receptor signaling d..:

Eken, Janneke A. ; Koning, Marvyn T. ; Kupcova, Kristyna...
Journal of Experimental Medicine. 221 (2024) 5 - p. , 2024

Link: https://doi.org/10.1084/..

6

The degree of HLA matching determines the incidence of cyto..:

von dem Borne, Peter A. ; Kemps-Mols, Berit M. ; de Wreede, Liesbeth C....
Leukemia & Lymphoma. , 2024

Link: https://doi.org/10.1080/..

7

Mapping AML heterogeneity - multi-cohort transcriptomic ana..:

Severens, Jeppe F. ; Karakaslar, E. Onur ; van der Reijden, Bert A....
Leukemia. 38 (2024) 4 - p. 751-761 , 2024

Link: https://doi.org/10.1038/..

8

A transcriptomic based deconvolution framework for assessin..:

Karakaslar, E. Onur ; Severens, Jeppe F. ; Sánchez-López, Elena...
npj Precision Oncology. 8 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

9

Probing entanglement and testing Bell inequality violation ..:

Ehatäht, K. ; Fabbrichesi, M. ; Marzola, L..
Physical Review D. 109 (2024) 3 - p. , 2024

Link: https://doi.org/10.1103/..

10

Expanding the repertoire reveals recurrent, cryptic, and he..:

Fuchs, Kyra J. ; van de Meent, Marian ; Honders, M. Willy...
Blood. 143 (2024) 18 - p. 1856-1872 , 2024

Link: https://doi.org/10.1182/..

11

Risk factors for graft-versus-host-disease after donor lymp..:

Koster, Eva A. S. ; von dem Borne, Peter A. ; van Balen, Peter...
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

12

R‐CODOX‐M/R‐IVAC VERSUS DA‐EPOCH‐R IN PATIENTS WITH NEWLY D..:

Chamuleau, M. ; Stenner, F. ; Chitu, D....
Hematological Oncology. 41 (2023) S2 - p. 50-51 , 2023

Link: https://doi.org/10.1002/..

13

Prognosis of IGLV3-21R110 chronic lymphocytic leukemia afte..:

Hengeveld, Paul J. ; Veelken, Hendrik ; van Bergen, Cornelis A. M....
Leukemia. 37 (2023) 9 - p. 1929-1932 , 2023

Link: https://doi.org/10.1038/..

14

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly d..:

Chamuleau, Martine E D ; Stenner, Frank ; Chitu, Dana A...
The Lancet Haematology. 10 (2023) 12 - p. e966-e975 , 2023

Link: https://doi.org/10.1016/..

15

Feasibility, safety, and efficacy of early prophylactic don..:

van der Zouwen, Boris ; Koster, E. A. S. ; von dem Borne, P. A....
Annals of Hematology. 102 (2023) 5 - p. 1203-1213 , 2023

Link: https://doi.org/10.1007/..